Medifast logo

MedifastNYSE: MED

Profile

Country:

United States

IPO:

30 December 1993

Next earnings report:

20 February 2025

Last dividends:

18 September 2023

Next dividends:

N/A
$191.63 M
-92%vs. 3y high
33%vs. sector
-12%vs. 3y high
74%vs. sector
-94%vs. 3y high
38%vs. sector
-84%vs. 3y high
21%vs. sector

Price

regular market | 7 min ago
$17.52-$0.29(-1.63%)
$140.16 M$114.25 M
$140.16 M$1.13 M

Analysts recommendations

Institutional Ownership

MED Latest News

How Should You Play Medifast Stock at a P/E Multiple of 17.6X?
zacks.com19 November 2024 Sentiment: -

MED is battling customer acquisition challenges and high SG&A costs, while its strategic growth efforts keep it well-positioned for long-term success.

Are Investors Undervaluing MEDIFAST (MED) Right Now?
zacks.com07 November 2024 Sentiment: POSITIVE

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

MED Q3 Earnings Beat, Revenues Fall on Customer Acquisition Challenges
zacks.com05 November 2024 Sentiment: NEGATIVE

Medifast's Q3 results lower earnings and revenues, highlighting challenges in customer acquisition. Management issues soft guidance for the fourth quarter.

Medifast, Inc. (MED) Q3 2024 Earnings Call Transcript
seekingalpha.com04 November 2024 Sentiment: NEUTRAL

Medifast, Inc. (NYSE:MED ) Q3 2024 Earnings Conference Call November 4, 2024 4:30 PM ET Company Participants Steven Zenker - Vice President-Investor Relations Dan Chard - Chairman & Chief Executive Officer Jim Maloney - Chief Financial Officer Conference Call Participants Jim Salera - Stephens Inc. Linda Bolton-Weiser - D.A. Davidson Operator Greetings, and welcome to the Medifast Third Quarter 2024 Earnings Conference Call.

Medifast Drives Growth With Weight Loss Transformation Strategies
zacks.com07 October 2024 Sentiment: POSITIVE

MED is striving to excel in the evolving weight loss market where GLP-1 medication adoption is reshaping the industry dynamics amid macroeconomic challenges.

The Schall Law Firm Invites Shareholder Participation In A Securities Fraud Inquiry Into Medifast, Inc.
accesswire.com27 September 2024 Sentiment: NEGATIVE

LOS ANGELES, CA / ACCESSWIRE / September 27, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Medifast Inc Is Being Investigated For Violating Securities Laws And Investors Are Urged To Contact The Schall Law Firm
accesswire.com26 September 2024 Sentiment: NEGATIVE

LOS ANGELES, CA / ACCESSWIRE / September 26, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

The Schall Law Firm Encourages Shareholder Participation In An Inquiry Into Medifast, Inc. For Securities Fraud
accesswire.com21 September 2024 Sentiment: NEGATIVE

LOS ANGELES, CA / ACCESSWIRE / September 21, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Medifast Inc May Have Violated Securities Laws And Investors Are Urged To Help The Schall Law Firm Investigate
accesswire.com20 September 2024 Sentiment: NEGATIVE

LOS ANGELES, CA / ACCESSWIRE / September 20, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

The Schall Law Firm Seeks Shareholder Participation In An Inquiry Into Medifast, Inc. For Possible Securities Fraud
accesswire.com19 September 2024 Sentiment: NEGATIVE

LOS ANGELES, CA / ACCESSWIRE / September 19, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

What type of business is Medifast?

Medifast, Inc. is an American company that specializes in the development, production, and sales of special nutrition and weight control programs, as well as products for a healthy lifestyle. The company is based in Baltimore, Maryland and was founded in 1980. Medifast, Inc.'s products and programs are developed in collaboration with scientists and doctors specifically for clients to help them achieve optimal weight and get into a healthy shape. The company's products focus on developing the right dietary plan for each client, motivation and workout programs, and instilling healthy habits.

What sector is Medifast in?

Medifast is in the Consumer Cyclical sector

What industry is Medifast in?

Medifast is in the Personal Services industry

What country is Medifast from?

Medifast is headquartered in United States

When did Medifast go public?

Medifast initial public offering (IPO) was on 30 December 1993

What is Medifast website?

https://medifastinc.com

Is Medifast in the S&P 500?

No, Medifast is not included in the S&P 500 index

Is Medifast in the NASDAQ 100?

No, Medifast is not included in the NASDAQ 100 index

Is Medifast in the Dow Jones?

No, Medifast is not included in the Dow Jones index

When was Medifast the previous earnings report?

No data

When does Medifast earnings report?

The next expected earnings date for Medifast is 20 February 2025